TET2 and angioimmunoblastic T-cell lymphoma: In patients with AITL/TCL‐TFH, the TET2 and DNMT3A mutations detected in neoplastic TFH cells are also seen in non‐neoplastic B and CD8+ T cells.4, 11, 12, 13